BIOLINQ Trademark

Trademark Overview

On Wednesday, February 13, 2019, a trademark application was filed for BIOLINQ with the United States Patent and Trademark Office. The USPTO has given the BIOLINQ trademark a serial number of 88300711. The federal status of this trademark filing is REGISTERED as of Tuesday, October 20, 2020. This trademark is owned by Biolinq Incorporated. The BIOLINQ trademark is filed in the Medical Instrument Products category with the following description:

wearable sensor for monitoring glucose
biolinq

General Information

Serial Number88300711
Word MarkBIOLINQ
Filing DateWednesday, February 13, 2019
Status700 - REGISTERED
Status DateTuesday, October 20, 2020
Registration Number6177544
Registration DateTuesday, October 20, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 1, "Inc. " should be deleted, and "Incorporated" should be inserted.
Goods and Serviceswearable sensor for monitoring glucose

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 7, 2019
Primary Code010
First Use Anywhere DateTuesday, December 18, 2018
First Use In Commerce DateTuesday, December 18, 2018

Trademark Owner History

Party NameBiolinq Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, December 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 30, 2022CORRECTION UNDER SECTION 7 ¿ PROCESSED
Wednesday, June 29, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 28, 2022TEAS SECTION 7 REQUEST RECEIVED
Monday, November 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 20, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 1, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 1, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 1, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2020NON-FINAL ACTION E-MAILED
Thursday, January 16, 2020NON-FINAL ACTION WRITTEN
Thursday, January 2, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, December 3, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, November 15, 2019ASSIGNED TO LIE
Wednesday, November 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 24, 2019ASSIGNED TO EXAMINER
Thursday, March 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 16, 2019NEW APPLICATION ENTERED

Related Keywords

biolinq glucose monitoring sensor wearable